(3R,4R)-tert-Butyl 3-bromo-4-hydroxypyrrolidine-1-carboxylate, 100mg

(2,6-Dimethylpyridin-4-yl)methanol, 97.0%, 250mg

2-methoxy-6-[(piperidin-4-yl)methoxy]pyridine dihydrochloride, 1g

6-(Trifluoromethyl)-pyrimidine-4-carboxylic acid, 95%, 500mg

tert-Butyl 2-(2-aminoethyl)-2,7-diazaspiro[3.5]nonane-7-carboxylate dihydrochloride, 97%, 1g

4-Chloro-2-(pyrrolidin-1-yl)pyridine, 98%, 1g

1-[2-nitro-4-(trifluoromethyl)phenyl]-1H-imidazole, 250mg

1-(2,6-DIBROMO-4-ISOPROPYLPHENYL)-3-(PYRIDIN-3-YL)UREA, 95%, 250mg

4-nitrobenzyl alcohol, min. 99%, for synthesis, 100 g, glass packaging

4-[(3-methylpiperidin-1-yl)methyl]-1,3-thiazol-2-amine, 1g

2-(4-Amino-3-methylphenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol, 95.0%, 100mg

1,1,4,4,7,7,10,10-Octamethyl-2,3,4,7,8,9,10,12-octahydro-1H-dibenzo[b,h]fluorene, 95.0%, 5g

5,7-Dichloro-1-methyl-1H-pyrazolo[4,3-d]pyrimidine, 95.0%, 5g